文献速递眼底病与葡萄膜炎神经眼科

多巴胺缺乏介导糖尿病小鼠早期视杆细胞驱动的内层视网膜功能障碍

Dopamine Deficiency Mediates Early Rod-Driven Inner Retinal Dysfunction in Diabetic Mice.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2018-01-01

本研究在链脲佐菌素诱导的糖尿病小鼠中,于诱导后3、4、5周行暗适应视网膜电图(ERG),分析振荡电位(OPs)与视网膜多巴胺(DA)水平的相关性,并通过L-DOPA治疗和视网膜特异性酪氨酸羟化酶敲除小鼠(rTHKO)评估DA的作用。结果发现糖尿病动物在暗闪光刺激下OPs显著延迟,L-DOPA可保留OP隐含时间,视网膜DA降低与视杆通路介导的OP延迟显著相关。作者认为早期糖尿病内层视网膜功能障碍由视杆通路缺陷和DA缺乏介导,OP延迟或可用于确定糖尿病视网膜病变最早的功能缺陷和DA治疗的早期时间窗。

要点

  • 糖尿病小鼠在暗闪光刺激下振荡电位(OPs)显著延迟,明闪光刺激下无此改变。
  • L-DOPA治疗可保留糖尿病小鼠的OP隐含时间。
  • 视网膜DA水平降低与视杆通路介导的OP延迟显著相关。

核心结论

  • 作者认为早期糖尿病内层视网膜功能障碍由视杆通路缺陷和多巴胺缺乏介导。
  • OP延迟或可用于确定糖尿病视网膜病变最早的功能缺陷,并建立DA治疗的早期时间窗以可能预防进行性视力丧失。

研究设计与样本

  • 研究在链脲佐菌素诱导的糖尿病小鼠中,于糖尿病诱导后3、4、5周行暗适应ERG检测视网膜功能。
  • 分析电反应并与既往报告的视网膜DA水平进行相关性分析。
  • 通过L-DOPA治疗恢复全身DA水平,以及视网膜特异性酪氨酸羟化酶敲除小鼠(rTHKO)去除视网膜DA,评估对OPs的影响。

主要发现

  • 糖尿病动物在暗闪光刺激下OPs较对照动物显著延迟,明闪光刺激下无显著延迟。
  • L-DOPA治疗保留了糖尿病小鼠的OP隐含时间。
  • 糖尿病rTHKO小鼠较视网膜Th正常的糖尿病小鼠OPs进一步延迟,L-DOPA治疗也提供益处。
  • 视网膜DA水平降低与视杆通路介导的OP延迟增加显著相关。

临床怎么用

  • 作者认为OP延迟或可用于确定糖尿病视网膜病变最早的功能缺陷,并建立DA治疗的早期时间窗以可能预防进行性视力丧失。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Electroretinograms (ERGs) are abnormal in diabetic retinas before the appearance of vascular lesions, providing a possible biomarker for diabetic vision loss. Previously, we reported that decreased retinal dopamine (DA) levels in diabetic rodents contributed to early visual and retinal dysfunction. In the current study, we examined whether oscillatory potentials (OPs) could serve as a potential marker for detecting early inner retinal dysfunction due to retinal DA deficiency. METHODS: Retinal function was tested with dark-adapted ERGs, taken at 3, 4, and 5 weeks after diabetes induction with streptozotocin. Electrical responses were analyzed and correlations were made with previously reported retinal DA levels. The effect of restoring systemic DA levels or removing DA from the retina in diabetic mice on OPs was assessed using L-3,4-dihydroxyphenylalanine (L-DOPA) treatments and retina-specific tyrosine hydroxylase (Th) knockout mice (rTHKO), respectively. RESULTS: Diabetic animals had significantly delayed OPs compared to control animals in response to dim, but not bright, flash stimuli. L-DOPA treatment preserved OP implicit time in diabetic mice. Diabetic rTHKO mice had further delayed OPs compared to diabetic mice with normal retinal Th, with L-DOPA treatment also providing benefit. Decreasing retinal DA levels significantly correlated with increasing OP delays mediated by rod pathways. CONCLUSIONS: Our data suggest that inner retinal dysfunction in early-stage diabetes is mediated by rod-pathway deficits and DA deficiencies. OP delays may be used to determine the earliest functional deficits in diabetic retinopathy and to establish an early treatment window for DA therapies that may prevent progressive vision loss.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Kim MK, Aung MH, Mees L, et al. Dopamine Deficiency Mediates Early Rod-Driven Inner Retinal Dysfunction in Diabetic Mice. Invest Ophthalmol Vis Sci. 2018. PMID: 29372256. doi:10.1167/iovs.17-22692

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。